Clinical Trial Site

Plano, Texas 75075

3 studies enrolling now · 7 studies all time

What they study most

AQP4+ NMOSD, Familial Amyloidotic Cardiomyopathy (FAC), High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, NMOSD, Neuromyelitis Optica Spectrum Disorder, Non-infectious Intermediate Uveitis, Non-infectious Pan Uveitis, Non-infectious Posterior Uveitis, Transthyretin Amyloidosis With Cardiomyopathy, Uveitis

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — Recruiting now
• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis — Running, not enrolling
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed
• A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis — Completed
• DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis — Completed